Found 0 matching trials
Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus PHASE2 The purpose of this study is to learn how well a combination of iparomlimab...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Learn More & Join Trial
Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma NA This project is a prospective, multi-center, multi-cohort exploratory clini...
Show More Location
China Pharmaceutical University Affiliated Nanjing Tianyinshan Hospital
Learn More & Join Trial
A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification PHASE2 This study was designed to evaluate the effectiveness and safety of hepatic...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
HAIC Plus Lenvatinib and PD-1 Antibody Versus HAIC Plus Lenvatinib for Advanced HCC PHASE2 The purpose of this study is to evaluate the efficacy and safety of hepatic...
Show More Location
Cancer Center Sun Yat-sen University
Learn More & Join Trial
HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer NA Biliary tract cancer (BTC), including cholangiocarcinoma and gallbladder ca...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial
HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC PHASE2 To Evaluate the Efficacy and Safety of the Hepatic Arterial Infusion Chemot...
Show More Location
Tianjin Medical University Cancer Institute & Hospital
Learn More & Join Trial
BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases PHASE2 This single-center, prospective, single-arm Phase II clinical trial is desi...
Show More Location
Shandong Cancer Hospital and Institute
Learn More & Join Trial
EDN Combined With TACE/HAIC and Second-Line Immune-Targeted Treatment Versus TACE/HAIC Alone in Locally Advanced HCC With Portal Vein Tumor Thrombosis After First-Line Therapy Failure: A Prospective, Multicenter, Randomized Controlled Trial PHASE1 The goal of this clinical trial is to evaluate the efficacy and safety of c...
Show More Location
Zhongda Hospital Affiliated to Southeast University, Department of Interventional and Vascular Surgery
Learn More & Join Trial
FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma PHASE2 This is a prospective, open-label, single-arm phase II study designed to ev...
Show More Location
Sun Yat-san University Cancer Center
Learn More & Join Trial
Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma NA This is a prospective, single-arm, phase II clinical study designed to eval...
Show More Location
Multiple Locations
Learn More & Join Trial